7 March 2014
New England Biolabs® announces supply agreement with Lumora
5th March, 2014 (Ipswich, MA, USA) New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing molecular...
26 February 2014
Prime Minister David Cameron visits portfolio company Oxford Cryosystems
The Prime Minister, David Cameron, recently visited Oxford Cryosystems in Long Hanborough to meet executives and staff from the market-leading manufacturer of specialist scientific instrumentation and software. During his visit, Mr Cameron toured the production site with...
29 January 2014
Michelson Diagnostics targets malignant melanoma using OCT imaging with €2.3M EU funding
Portfolio company Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces that the European Union has awarded a €2.26 million Framework 7 grant to a consortium of seven partners...
13 January 2014
Michelson Diagnostics announces £1.98 million financing
Portfolio company Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, is delighted to announce the first closing of its Series A2 Financing. The round, which was oversubscribed, raised...
11 December 2013
Oxford BioTherapeutics and Menarini Progress Enhanced Antibody for Acute Myeloid Leukemia in $1 Billion Oncology Investment Alliance
OXFORD, UK and BERLIN CHEMIE/MENARINI, GERMANY – 9th December 2013 – Oxford BioTherapeutics (OBT) and Berlin-Chemie (Menarini Group) announce today that they have designated a novel enhanced antibody targeting acute myeloid leukemia (AML) as the first clinical...
14 November 2013
Zysis Receives US Patent for Long Acting Oral Aripiprazole Once Weekly
Portfolio company Zysis, a private pharmaceutical company optimising therapies for disorders of the Central Nervous System, today announced that the United States Patent and Trademark Office has granted U.S. patent 8,575,172 covering its Phase II ready Long Acting Oral...
6 November 2013
Technology Strategy Board awards Accutronics £100,000 for medical battery
Portfolio company Accutronics has received a Smart Award from the UK’s innovation agency, the Technology Strategy Board. The company received a £100,000 grant to support ‘proof of concept’ work on a new high voltage, high capacity battery for the medical...
1 November 2013
Patent Published for Lumora’s Novel Sample Preparation Technology
Cambridgeshire, UK, 31 October 2013 ... Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has received a patent for its Heat Elution Sample Preparation, technology which has the potential to help commercial laboratories...
18 October 2013
PolyTherics and TUBE Pharma collaborate to develop novel cytotoxic payloads for antibody drug conjugates (ADCs)
London, UK and Vienna, Austria, 15 October 2013 - PolyTherics Limited (“PolyTherics”) and TUBE Pharma GmbH (“TUBE”) announce that they are collaborating to produce reagents to link novel cytotoxic drugs developed by TUBE to antibodies using...
16 October 2013
Innovative new Blade Inspection System launched
Limpet Technology has signed an exclusive 2-year agreement with portfolio company RTS International to provide an innovative blade and turbine inspection system using the skills and expertise from each company. The signatures mark the end of a 2 year R&D Project initiated by...